Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy of Vonoprazan-based Rescue Therapy for H. Pylori Eradication
Sponsor: National Taiwan University Hospital
Summary
1. This study aims to compare the efficacy of empirical vonoprazan-based therapy versus susceptibility-guided vonoprazan-based therapy for third-line eradication of H. pylori. 2. We also plan to explore the impact of eradication therapy on gut microbiota, fecal antibiotic resistance, and metabolic parameters before and after treatment.
Key Details
Gender
All
Age Range
20 Years - Any
Study Type
INTERVENTIONAL
Enrollment
220
Start Date
2025-08-18
Completion Date
2030-06-30
Last Updated
2025-08-19
Healthy Volunteers
No
Conditions
Interventions
Vonoprazan based ET
Empirical therapy Based on drug history: Levofloxacin sequential therapy or bismuth quadruple therapy (10 or 14 days) or quadruple therapy
Vonoprazan based SGT
Susceptibility testing guided therapy Based onsusceptibility test:Levofloxacin sequential therapy or bismuth quadruple therapy (10 or 14 days) or rifabutin quadruple therapy
Locations (1)
National Taiwan University Hospital
Taipei, Taiwan